Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-25-000017

Chief People Officer gave up 4,103 shares (to pay taxes)

  • Chief People Officer acquired 56,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schick Kelly · Chief People Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-13 Shares withheld for taxes : show line 1 in the form −1,735 $3.20 $5,552 54,753 D
2025-02-14 Grant or award : show line 2 in the form +56,500 111,253 D
2025-02-14 Shares withheld for taxes : show line 3 in the form −2,368 $3.18 $7,530 108,885 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-14 Grant or award : show line 4 in the form Stock Option (Right to Buy) +84,700 84,700 D
Loading xslF345X05/wk-form4_1739915691.xml…